Quanterix Corp
About Quanterix Corp
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $138.9M
- Net income
- -$107.2M
- Total assets
- $418.8M
- Market cap
- $155.4M
- Gross margin
- 46.8%
- Operating margin
- -90.4%
- Net margin
- -77.1%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $138.9M
- Cost of revenue
- $73.9M
- Gross profit
- $65.0M
- Operating expenses
- $190.5M
- Operating income
- -$125.5M
- Income tax
- -$5.1M
- Net income
- -$107.2M
- EPS (basic)
- $-2.51
- EPS (diluted)
- $-2.51
Balance sheet
- Total assets
- $418.8M
- Current assets
- $212.3M
- Total liabilities
- $123.0M
- Current liabilities
- $74.8M
- Shareholders’ equity
- $295.7M
Cash flow
- Operating cash flow
- -$77.2M
- Investing cash flow
- $50.2M
- Financing cash flow
- -$708.0K
- Net cash flow
- -$26.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $155.4M
- EPS (diluted)
- $-2.51
- Shares outstanding
- 49.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 7, 2017
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $107.2M in FY2025.
- Revenue grew 26% from FY2021 to FY2025.
- Gross margin of 46.8%, net margin -77.1%.
- Trading 61% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Quanterix Corp.
Write a review
News about Quanterix Corp
News & sentiment via Polygon.io
